Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

JFL Life Sciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:535469 P/E (TTM) :14.73
ISIN Demat:INE0LA901015 Div & Yield %:0 EPS (TTM) :0.73
Book Value (RS) :11.3920003 Market Cap (Rs Cr.):70.94 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.220.190.531.802.13
Long Term Debt-Equity Ratio0.010.030.220.910.78
Current Ratio1.962.361.831.411.23
Fixed Assets6.104.234.834.054.73
Inventory4.203.263.093.256.91
Debtors2.701.932.032.132.68
Interest Cover Ratio6.695.413.622.831.60
PBIDTM (%)10.0110.9612.9818.616.87
PBITM (%)8.8010.0111.9817.516.01
PBDTM (%)8.699.119.6712.413.11
CPM (%)6.288.037.569.472.50
APATM (%)5.077.096.568.371.65
ROCE (%)15.7711.4915.4223.1010.23
RONW (%)11.099.7312.9030.938.82

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)